AIMCA
VRTX icon

Alberta Investment Management Corp (AIMCo)’s Vertex Pharmaceuticals VRTX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,686
Closed -$6.15M – 915
2025
Q1 		$6.15M Buy
+12,686
New +$5.91M 0.04% 254
2024
Q2 		– Sell
-5,700
Closed -$2.38M – 1033
2024
Q1 		$2.38M Hold
5,700
– – 0.02% 382
2023
Q4 		$2.32M Hold
5,700
– – 0.02% 390
2023
Q3 		$1.98M Hold
5,700
– – 0.02% 451
2023
Q2 		$2.01M Sell
5,700
-183
-3% -$61.7K 0.02% 542
2023
Q1 		$1.85M Sell
5,883
-1,002
-15% -$301K 0.02% 571
2022
Q4 		$1.99M Sell
6,885
-34,317
-83% -$10.5M 0.02% 640
2022
Q3 		$11.9M Hold
41,202
– – 0.09% 241
2022
Q2 		$11.6M Sell
41,202
-49,998
-55% -$13.4M 0.08% 247
2022
Q1 		$23.8M Buy
91,200
+12,000
+15% +$2.85M 0.14% 156
2021
Q4 		$17.4M Sell
79,200
-12,452
-14% -$2.42M 0.11% 196
2021
Q3 		$16.6M Sell
91,652
-4,910
-5% -$959K 0.14% 148
2021
Q2 		$19.5M Sell
96,562
-5,463
-5% -$1.14M 0.16% 141
2021
Q1 		$21.9M Sell
102,025
-17,175
-14% -$3.77M 0.2% 111
2020
Q4 		$28.2M Buy
119,200
+62,600
+111% +$14.4M 0.25% 90
2020
Q3 		$15.4M Buy
56,600
+16,300
+40% +$4.5M 0.17% 142
2020
Q2 		$11.7M Buy
40,300
+37,800
+1,512% +$10.2M 0.14% 179
2020
Q1 		$595K Buy
+2,500
New +$573K 0.01% 694
2019
Q3 		– Sell
-8,200
Closed -$1.5M – 1012
2019
Q2 		$1.5M Buy
8,200
+5,800
+242% +$1.01M 0.01% 551
2019
Q1 		$441K Buy
+2,400
New +$443K ﹤0.01% 770
2018
Q3 		– Sell
-12,200
Closed -$2.07M – 898
2018
Q2 		$2.07M Buy
12,200
+8,800
+259% +$1.36M 0.02% 458
2018
Q1 		$554K Sell
3,400
-4,800
-59% -$784K 0.01% 671
2017
Q4 		$1.23M Buy
+8,200
New +$1.21M 0.01% 522
2017
Q3 		– Sell
-5,300
Closed -$683K – 813
2017
Q2 		$683K Buy
+5,300
New +$638K 0.01% 611

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s VRTX Position: Q2 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 12,686 shares — an estimated $6.15M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in VRTX in Q2 2017 and held it in 24 quarters. The position peaked at $28.2M in Q4 2020. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 12,686 Vertex Pharmaceuticals shares in Q2 2025, an estimated $6.15M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Vertex Pharmaceuticals in Q2 2017 and held it in 24 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Vertex Pharmaceuticals position peaked at $28.2M in Q4 2020.
  • 1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2025, filed 8 Aug 2025.